1. Home
  2. HURC vs PLRX Comparison

HURC vs PLRX Comparison

Compare HURC & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HURC

Hurco Companies Inc.

HOLD

Current Price

$15.23

Market Cap

95.6M

Sector

Industrials

ML Signal

HOLD

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.24

Market Cap

93.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HURC
PLRX
Founded
1968
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
95.6M
93.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
HURC
PLRX
Price
$15.23
$1.24
Analyst Decision
Hold
Analyst Count
0
11
Target Price
N/A
$3.79
AVG Volume (30 Days)
31.6K
1.8M
Earning Date
01-09-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$186,789,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.19
$1.10
52 Week High
$23.45
$15.00

Technical Indicators

Market Signals
Indicator
HURC
PLRX
Relative Strength Index (RSI) 35.02 34.01
Support Level $14.70 $1.17
Resistance Level $15.38 $1.35
Average True Range (ATR) 0.66 0.12
MACD -0.06 -0.03
Stochastic Oscillator 21.49 15.38

Price Performance

Historical Comparison
HURC
PLRX

About HURC Hurco Companies Inc.

Hurco Companies Inc is a United States-based industrial technology company. It designs, manufactures, and sells computerized machine tools, consisting mainly of vertical machining centers and turning centers, to companies in the metalworking industry through sales, service, and distribution networks. The company concentrated on designing user-friendly computer control systems that both skilled and unskilled machine tool operators can operate. It generates maximum revenue from the Computerized Machine Tools product. Geographically, It derives a majority of its revenue from the United States of America. Its product categories include 5-Axis VMC; 3-Axis VMC; Horizontal MC and Turning Centers.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

Share on Social Networks: